Masafumi Koshiyama, MD, PhD, “Potential Efficacy of Anti-PD-1 or PD-L1 Antibody Treatments for Gynecologic Cancers”, Wom. Hea. – Open Jour., pp. e21 - e23, Nov. 2017.